TAK earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 45.13. Updated 2026-07-23.
Takeda Pharmaceutical (TAK) Research Hub
Takeda Pharmaceutical (TAK) trades on NYSE, JP in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-09-11, shares last closed at 18.26 USD (+0.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 45.13, market cap 53.91B. This hub links to the full technical, earnings and options research available for TAK.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NYSE, JP |
| Last close | 18.26 USD (+0.27%) |
| 52-week range | 15.34 USD – 18.84 USD |
| Trend regime | Range |
| 14-day RSI | 63.6 (Bullish) |
| Trailing P/E | 45.13 |
| Market cap | 53.91B |
| Dividend yield | 3.63% |
| Next earnings | 2026-07-30 |
Available research for TAK
Covered Call on TAK: how it works, illustrative setup around the real 18.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TAK: how it works, illustrative setup around the real 18.26 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TAK: how it works, illustrative setup around the real 18.26 USD price, max profit/loss, breakeven and when to use it. Educational.
TAK technical analysis: range, last 18.26 USD, RSI 63.6, 52w range 15.34 USD–18.84 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TAK in?
Takeda Pharmaceutical (TAK) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NYSE, JP.
Is TAK in an uptrend or downtrend?
As of 2026-09-11, TAK is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TAK's trailing P/E ratio?
TAK's trailing P/E is 45.13, with a market cap of 53.91B. See the earnings research page for full valuation detail.
When does TAK next report earnings?
TAK is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 0.1689 USD.